To bypass the undesired effects of TGF-β inhibitors on tumour cells, we decided to switch strategies and search for downstream mediators specific to TGF-β pro-tumorigenic actions, focusing our attention on NOX4, which is highly increased in iCCA compared to normal tissue. This evidence concerns the gene TGFB1 and neoplasm.